key: cord-0837371-g0wgiu1u authors: King, W. C.; Rubinstein, M.; Reinhart, A.; Mejia, R. J. title: COVID-19 vaccine hesitancy January-March 2021 among 18-64 year old US adults by employment and occupation date: 2021-04-23 journal: nan DOI: 10.1101/2021.04.20.21255821 sha: 065a92d057db809916b13c4e0a2878028c0b56ca doc_id: 837371 cord_uid: g0wgiu1u Introduction: COVID-19 vaccine hesitancy increased among US adults April-December, 2020, and threatens efforts to end the pandemic. Among US adults 18-64 years, we report prevalence of and reasons for vaccine hesitancy, overall and by employment and occupation, during the COVID-19 vaccine rollout. Methods: The Delphi Group at Carnegie Mellon University conducted a COVID-19 survey administered by Facebook. In January, February and March 2021, 791,716, 710,529, and 732,308 Facebook users, respectively, reported age 18-64 years and answered a vaccine acceptance question. Weights matched the sample to the age, gender, and state profile of the US population. Percentages and risk ratios (RR) for vaccine hesitancy were estimated using a weighted Poisson regression; 95% confidence intervals (CI) were calculated using robust standard errors. Results: Vaccine hesitancy decreased among adults 18-64 years from January (27.5% [95%CI, 27.3-27.6]) to March (22.1% [95%CI, 21.9-22.2]). Vaccine hesitancy varied widely by occupational category: 9.6%, (95%CI, 8.5-10.7) in life/physical/social sciences to 46.4% (95%CI, 45.1-47.7) in construction/extraction. Almost half (47.9%, 95%, 47.6-48.3) of hesitant participants indicated concern about side effects, and over a third did not believe they needed the vaccine, did not trust the government, were waiting to see if it was safe, and did not trust COVID-19 vaccines (versus 14.5% [95%CI, 14.3-14.8] who did not like vaccines in general). Conclusions: In this nationally representative survey of adults 18-64 years, vaccine hesitancy decreased to 22.1% by March, 2021. Still, hesitancy, which varies widely by occupation, remains a barrier to pandemic control. Reasons for hesitancy indicate messaging about safety and addressing trust are paramount. Vaccine hesitancy is a barrier to ending the COVID-19 pandemic. 1 Despite the COVID-19 death toll, 2 COVID-19 vaccine hesitancy increased among US adults April-December, 2020. 3 In early December, only 56.2% reported they were likely to get vaccinated 1 . The likelihood was similar among healthcare workers (HCW) (55.3%) 4 , and lower among working-age adults (<65 years) versus older adults 1 . Workplace outbreaks, spread of infection from HCW to patients and from workers to customers are public health threats. 5, 6 The extent to which vaccine hesitancy changed during the first three months of the US COVID-19 vaccine rollout, and if and how current vaccine hesitancy varies by employment is unknown. Among a large representative sample of US adults 18-64 years, we report vaccine hesitancy by month, January-March, 2021, and for March, cumulative COVID-19 vaccine uptake and current prevalence of and reasons for vaccine hesitancy, overall and by employment status and occupational category. Since April, 2020, the Delphi Group at Carnegie Mellon University (CMU) has been conducting an ongoing national COVID-19 survey in collaboration with the Facebook Data for Good group. Each month the survey is offered to a random sample, stratified by geographic region, of ≈100 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Study sample. Facebook users may be offered the survey more than once at different intervals depending on which strata they fall in, from once a month to once every six months. To show trends over time in vaccine hesitancy, we used data from January 6 (date the question was initially asked in its current form) to March 31, aggregated by month. While is possible there are repeat respondents across months, we cannot link respondents longitudinally, so data is treated as repeat cross-sectional surveys. In the primary analysis, we only use March data. In March, 2021, 104,768,154 Facebook users were offered the survey of whom 1,291,957 completed at least two survey questions. Respondents were excluded if they did not report age 18-64 (n=558,972) or did not answer the vaccine acceptance question (n=677), leaving 732,308 participants. Applying the same criteria, the January and February samples had 791,716 and 710,529 participants, respectively. Measures. The survey questions and response sets utilized in this report are provided in an appendix (supplemental material). Participants age 18-64 were categorized as vaccine hesitant if they answered that they probably or definitely would not choose to get vaccinated if offered a vaccine to prevent COVID-19 today (versus probably or definitely would choose to get vaccinated or were vaccinated). Participants were categorized by employment status in the past 4 weeks, and if employed, by occupational group and profession. Statistical analysis. Percentage vaccine hesitant by month (Jan-March 2021) was calculated using Facebook-provided weights, which account for the sampling design, non-response, and differences between the demographics of survey respondents and the US adult population. 7 Among the March 2021 sample, weighted percentages for worked outside the home, vaccinated, and vaccine hesitant were calculated, overall and by employment variables. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Reasons for vaccine hesitancy are reported in Table 2 overall and by occupational categories with at least one-third hesitant. Almost half (47.9%, 95%, 47.6-48.3) of hesitant participants indicated concern about side effects, and over a third didn't believe they needed the vaccine, didn't trust the government, were waiting to see if it was safe, and didn't trust COVID-19 vaccines (versus 14.5% [95%CI, 14.3-14.8] who didn't like vaccines in general). More than one fifth indicated allergic reaction risk, unknown efficacy and other people need more as reasons. Worry of side effects, an allergic reaction and a plan to wait and see if safe were reported less frequency among high-hesitancy occupational groups (versus all hesitant participants), whereas lack of trust in the COVID-19 vaccine and the government, disbelief of need and dislike of vaccines were more frequent ( Table 2) . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This data highlights the disparity in vaccine hesitancy by occupation. Among HCW, several professions with high patient contact (e.g., nursing assistants/psychiatric aides) reported hesitancy >20%. Occupational categories with the highest hesitancy (construction/extraction, installation/maintenance/repair, farming/fishing/forestry, transportation/material moving, and production), include some that have suffered workplace outbreaks. 5 Reasons for hesitancy indicate a need for messaging about safety and addressing trust. Thus, overall hesitancy prevalence estimates might be underestimated. 3 This should have minimal effects on time trends or comparisons between occupational categories. In this nationally representative survey of adults 18-64 years, vaccine hesitancy decreased from 27.5% to 22.1% January-March, 2021. Still, hesitancy among the workforce (21.8%), which varies widely by occupation, remains a barrier to pandemic control. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2021. ; https://doi.org/10.1101/2021.04.20.21255821 doi: medRxiv preprint Figure 1 . Vaccine hesitancy overall and by employment status, by month. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2021. ; (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Planning for a COVID-19 vaccination program Trends in number of COVID-19 cases and deaths in the United States reported to CDC, by state/territory National trends in the US public's likelihood of getting a COVID-19 vaccine Trends in health care workers intentions to receive a COVID-19 vaccine and reasons for hesitancy Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control Clusters of SARS-CoV-2 infection among elementary school educators and students in one school district -Georgia